266 billion won of business losses on Bio test scandals.

The KPMA reported that the government administrative measures against 287 drugs in charge of the bio equivalency test frauds resulted in about 266 billion won of economic losses a year, which excepted other losses accrued from a defamed industrial prestige and a loss of generic drug credibility.

The damages also included 29.1 billion won of sales loss for 48 drugs, an average 600 million w...